topSkip to main content

Menu, Secondary

Menu Trigger


AAU Comments on FDA International Drug Scheduling Proposal

AAU and many of our institutional members strongly object to any attempt to change international regulation of ketamine that would result in this drug being more difficult,or impossible, to obtain by biomedical researchers, health care providers, and licensed veterinarians for authorized and appropriate treatment of animals. In the United States, ketamine is currently a Schedule III drug under the Controlled Substances Act, and strict regulations and safeguards are already in place to prevent its illegal use.

Download the PDF